Kamran Alam
2019 - Aquinox Pharmaceuticals
In 2019, Kamran Alam earned a total compensation of $1.2M as Interim Chief Financial Officer and Vice President, Finance at Aquinox Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Salary | $390,800 |
|---|---|
| Other | $809,197 |
| Total | $1,199,997 |
Alam received $809.2K in other compensation, accounting for 67% of the total pay in 2019.
Alam also received $390.8K in salary.
Rankings
In 2019, Kamran Alam's compensation ranked 8,431st out of 13,971 executives tracked by ExecPay. In other words, Alam earned more than 39.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,431 out of 13,971 | 40th |
Division Manufacturing | 3,336 out of 5,695 | 41st |
Major group Chemicals And Allied Products | 1,261 out of 2,194 | 43rd |
Industry group Drugs | 1,071 out of 1,880 | 43rd |
Industry Pharmaceutical Preparations | 794 out of 1,392 | 43rd |
Source: SEC filing on March 24, 2020.
Alam's colleagues
We found two more compensation records of executives who worked with Kamran Alam at Aquinox Pharmaceuticals in 2019.
News
Taysha Gene Therapies CEO Sean Nolan's 2023 pay slips 20% to $1.5M
April 18, 2024
Taysha Gene Therapies CEO RA Session's 2022 pay falls 57% to $2M
May 8, 2023
Taysha Gene Therapies CEO RA Session's 2021 pay slips 3% to $4.6M
April 28, 2022
Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
April 24, 2020
Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
March 24, 2020
Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
October 2, 2019